Pulse Biosciences, Inc.
PLSENASDAQHealthcare● Active
$24.84
$-0.49(-1.93%)
Market Cap$1.7B
P/E Ratio—
52W High$28.53
52W Low$12.56
Pulse Biosciences, Inc. (PLSE) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PLSE · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($72.78M) | ($53.59M) | ($42.21M) | ($58.51M) | ($63.66M) |
| Depreciation & Amort. | $1.07M | $1.18M | $1.21M | $1.35M | $1.15M |
| Stock-Based Comp. | $21.46M | $13.59M | $7.18M | $5.19M | $14.60M |
| Change in Working Capital | ($5.02M) | $2.47M | $0.77M | ($3.72M) | ($6.20M) |
| Net Cash from Operations | ($54.12M) | ($36.34M) | ($33.04M) | ($47.01M) | ($54.10M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.32M) | ($0.13M) | ($0.12M) | ($0.40M) | ($0.44M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $8.00M |
| Net Cash from Investing | ($0.34M) | ($0.13M) | ($0.12M) | ($0.40M) | $7.56M |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $65.00M | $0.41M |
| Net Cash from Financing | $17.15M | $110.14M | $16.39M | $79.94M | $62.69M |
| Free Cash Flow | |||||
| Free Cash Flow | ($54.44M) | ($36.47M) | ($33.16M) | ($47.41M) | ($54.53M) |
| FCF Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Pulse Biosciences, Inc. data
About Pulse Biosciences, Inc. (PLSE) Cash Flow Statement
Pulse Biosciences, Inc. generated operating cash flow of ($0.05B) and free cash flow of ($0.05B) for 2025 — a FCF margin of -15553.43%. Capital expenditure was ($0.00B).
Frequently asked questions
PLSE · 4 questionsPulse Biosciences, Inc. generated free cash flow of ($0.05B) for 2025, down 49.3% year-over-year.
PLSE free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10